Clinical Trials Directory

Trials / Unknown

UnknownNCT06156722

The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay May Improve ICSI Outcome.

The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay Improves ICSI Outcomes: A Randomized Prospective Sibling-oocytes Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
189 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
Female
Age
18 Years – 38 Years
Healthy volunteers
Accepted

Summary

In this prospective randomized sibling-oocytes blinded study, investigators examine the combination of two sperm selection methods that logically seem to complete each other, and potentially may improve ICSI outcomes. The methods include the selection of the optimal spermatozoa based on its morphology by IMSI, together with its physiological function of binding to HA by Spermslow (SS). The current study compared a group of ET after sperm selection by IMSI with SS to a group of ET after sperm selection by IMSI-only without SS, and to a mixed ET group where two embryos were transferred, one after IMSI-only and the other one after IMSI with SS.

Conditions

Interventions

TypeNameDescription
PROCEDURESperm selection by IMSIIntracytoplasmic morphologically selected sperm injection (IMSI) is a sperm selection method used in intracytoplasmic sperm injection (ICSI)
PROCEDURESperm selection by IMSI and spermslowIntracytoplasmic morphologically selected sperm injection (IMSI) is a sperm selection method used in intracytoplasmic sperm injection (ICSI) + spermslow

Timeline

Start date
2019-03-01
Primary completion
2024-02-01
Completion
2024-02-01
First posted
2023-12-05
Last updated
2023-12-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT06156722. Inclusion in this directory is not an endorsement.